SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Jan-24 4:02 PM View: | Neostem, Inc. (LSTA) | 09-Jan-24 | Grant | 19,480 | -- | -- | 50% 39.2K to 58.68K | |
20-Dec-23 5:04 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 19-Dec-23 | Option Exercise | 4,320 | $9.85 | $42,552.00 | 6% 69.91K to 74.22K | |
11-Jan-23 4:12 PM View: | Neostem, Inc. (LSTA) | 09-Jan-23 | Grant | 20,000 | -- | -- | 104% 19.2K to 39.2K | |
13-Dec-22 4:29 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Dec-22 | Option Exercise | 3,086 | $2.68 | $8,270.48 | 5% 66.82K to 69.91K | |
16-Sep-22 4:46 PM View: | Neostem, Inc. (LSTA) | 15-Sep-22 | Grant | 19,200 | $6.25 | $120,000.00 | 100% 0 to 19.2K | |
25-May-22 8:03 PM View: | Durect Corp. (DRRX) | 24-May-22 | Private Purchase | 30,000 | $0.39 | $11,638.00 | 100% 30.0K to 60.0K | |
18-May-22 8:05 PM View: | Durect Corp. (DRRX) | 17-May-22 | Purchase | 20,000 | $0.42 | $8,406.51 | 200% 10.0K to 30.0K | |
18-May-22 8:05 PM View: | Durect Corp. (DRRX) | 16-May-22 | Private Purchase | 10,000 | $0.38 | $3,767.00 | 100% 0 to 10.0K | |
17-Dec-21 4:04 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Dec-21 | Option Exercise | 3,086 | $3.67 | $11,325.60 | 5% 63.73K to 66.82K | |
15-Dec-20 4:39 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Dec-20 | Option Exercise | 3,086 | $3.76 | $11,603.40 | 5% 60.65K to 63.73K | |
17-Dec-19 5:04 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 16-Dec-19 | Option Exercise | 3,086 | $3.56 | $10,986.20 | 5% 57.56K to 60.65K | |
17-Sep-19 4:46 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Sep-19 | Market Sale | 23 | $9.31 | $214.18 | (< 1%) 57.58K to 57.56K | < 1% |
10-Dec-18 9:10 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 06-Dec-18 | Option Exercise | 3,086 | $3.07 | $9,474.02 | 6% 54.5K to 57.58K | < 1% |
22-Jun-18 4:39 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 21-Jun-18 | Option Exercise | 10,288 | $3.70 | $38,065.60 | 23% 44.21K to 54.5K | |
16-Nov-17 4:56 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Nov-17 | Market Purchase | 15,000 | $2.22 | $33,280.50 | 51% 29.21K to 44.21K | |
25-Sep-17 5:00 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 22-Sep-17 | Market Purchase | 8,000 | $2.95 | $23,600.00 | 38% 21.21K to 29.21K | 94% |
25-Sep-17 5:00 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 21-Sep-17 | Market Purchase | 2,000 | $2.95 | $5,900.00 | 10% 19.21K to 21.21K | 94% |
21-Aug-17 4:49 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 18-Aug-17 | Market Purchase | 6,312 | $2.90 | $18,301.60 | 49% 12.9K to 19.21K | 97% |
21-Aug-17 4:49 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 17-Aug-17 | Market Purchase | 23 | $2.65 | $60.95 | < 1% 12.88K to 12.9K | 116% |
02-Dec-16 6:05 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Dec-16 | Payment of Exercise | 4,408 | $7.80 | $34,382.40 | (26%) 17.28K to 12.88K | |
02-Dec-16 6:05 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Dec-16 | Option Exercise | 12,345 | $3.21 | $39,627.40 | 250% 4.94K to 17.28K | |
14-Dec-15 5:37 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 11-Dec-15 | Option Exercise | 2,469 | $5.22 | $12,888.20 | 100% 2.47K to 4.94K | |
12-Jan-15 7:04 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 08-Jan-15 | Option Exercise | 2,469 | $4.98 | $12,295.60 | 100% 0 to 2.47K | |
16-Oct-13 7:31 PM View: | SuperGen Inc. (ASTX) | 11-Oct-13 | Disposition (change in control) | 8,753 | -- | -- | (100%) 8.75K to 0 | |
25-May-05 3:58 PM View: | QLT Inc. (NVLNF) | 24-May-05 | Market Purchase | 1,000 | $10.28 | $10,275.90 | 500% 0.2K to 1.2K | (63%) |